In the study of SBRT for the treatment of lung cancer, two studies have helped to demonstrate the treatment option’s efficacy.
Researchers of the Japan Clinical Oncology Group presented a study to the American Society for Radiation Oncology showing that in some cases, SBRT can be more effective than comparable treatments. In this study, SBRT for early stage, medically inoperable non-small cell lung cancer (NSCLC) helped to double overall survival rates as compared to conventional radiation treatment.
A second study focused on SBRT for NSCLC in elderly patients. The study discusses the positive impact of using SBRT treatment as an alternative for those who are unfit to undergo surgery.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.